A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment. H2020 project funded by EC under GA 875392
.@FraunhoferITWM leverages mathematics to implement innovations in several industries - no wonder it is another valuable ONCORELIEF partner! Learn more at https://t.co/KCtosMJ83U
Lucky to partner with @Unibo the oldest university in the Western world: it paves the way for innovation through an increasingly rich programme catalogue, cutting-edge research and a constant & increasingly broad international perspective. Very fitting for ONCORELIEF innovations!
.@suite5eu Data Intelligence Solutions is an ONCORELIEF partner - and an Information Technology Solutions and Services SME with the mission to deliver innovative data-driven intelligence solutions through state-of-the art technologies.
https://t.co/ObcZ9AdOal
Time to meet another ONCORELIEF partner: @CERTHellas. CERTH is one of the leading research centres in Greece & listed among the TOP-15 E.U. institutions with the highest participation in competitive research grants.
https://t.co/suk7hWKKvC
.@innosystems has been an instrumental partner for ONCORELIEF. Being an SME focused in innovation in Information Systems, colleagues led various activities to bring #ArtificialIntelligence to clinicians for the benefit of #cancer patients' #QualityOfLife
Among ONCORELIEF clinical partners is @IRSTDinoAmadori, a multispeciality #cancer institute founded in 2007 for the treatment of solid and haematological tumors. Colleagues have been greatly contributing to the introduction of #ArtificialIntelligence for patients' #QualityOfLife
ONCORELIEF partners include @Gruppo_Maggioli, a well-established technology company which demonstrates its leadership in R&D projects of all sizes. We are thankful for the ongoing contributions towards the #ArtificialIntelligence innovations for #qualityoflife of cancer patients
Among our partners is @FC_UL, with colleagues who have lengthy expertise in cancer, from a very interdisciplinary perspective. We are happy to be collaborating towards improving #cancer patients' #QualityOfLife#H2020#ArtificialIntelligence
#ASCO2023 made headlines with promising new treatments, artificial intelligence tools for diagnosis, and even trials testing yoga. But how much is just hype? Our experts talk us through the big cancer research stories from @ASCO 👇 https://t.co/StxaUzdMh9 https://t.co/StxaUzdMh9
In an analysis of #AcuteMyeloidLeukemia patients (among others), vulnerability was found to have a higher impact on their #QualityOfLife compared to disease risk https://t.co/JVIMuRgsOM
#leusm
The legal and ethical advisor of the ONCORELIEF #H2020 project is @timelex_lawfirm: A leading niche law firm specialised in the legal aspects of information technology, privacy & data protection, intellectual property, and media & electronic communications
Day 7 of #EWAC2023 is #WorldNoTobaccoDay🚭
#EUCancerPlan set a very clear objective - a tobacco-free generation in Europe, where less than 5% of people use tobacco by 2040!
Join the Europe-wide conversation about cancer ➡️https://t.co/mJAsKfmsS5
#EWAC#EWAC23
Day 6 of #EWAC2023 is about the role #ehealth and digital tools can play in the future of the fight against cancer.
Join the Europe-wide conversation about cancer ➡️https://t.co/mJAsKfmsS5
#EWAC#EWAC23#EUCancerPlan#EHDS
Cancer patients and survivors are at the core of what we all do. At @OncoRelief, specifically, we focus on the #QualityOfLife of patients and often this is not often relayed by their caregivers, but it also affects them directly. We are honored to be part of such efforts.
Day 5 of #EWAC2023 is dedicated to those touched by cancer - patients and survivors.
High-quality care and support for patients and survivors is a crucial part of the fight against cancer.
Join #EWAC ➡️https://t.co/mJAsKfmsS5
#EUCancerPlan#EWAC23@CancerLeagues@EU_Health